Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience

首页> 外文期刊>The journal of asthma >Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience

【24h】

Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience

机译：含有严重嗜酸性嗜酸性哮喘的青少年的Mepolizumab不符合omalizumab：一个中心的早期临床经验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《The journal of asthma》 |2020年第5期|共4页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience [J] . The journal of asthma . 2020,第5期

机译：含有严重嗜酸性嗜酸性哮喘的青少年的Mepolizumab不符合omalizumab：一个中心的早期临床经验
2. MEPOLIZUMAB IN ADOLESCENTS WITH SEVERE EOSINOPHILIC ASTHMA NOT ELIGIBLE FOR OMALIZUMAB: ONE CENTRE'S EXPERIENCE [J] . Weir E., Paton J. Y. Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：Mepolizumab在具有严重的嗜酸性嗜溶症哮喘的青少年不符合omalizumab：一个中心的经验
3. MEPOLIZUMAB IN ADOLESCENTS WITH SEVERE EOSINOPHILIC ASTHMA NOT ELIGIBLE FOR OMALIZUMAB: ONE CENTRE'S EXPERIENCE [J] . Weir E., Paton J. Y. Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：Mepolizumab在具有严重的嗜酸性嗜溶症哮喘的青少年不符合omalizumab：一个中心的经验
4. A SINGLE-CENTER EXPERIENCE USING CHEMOTHERAPY WITH MELPHALAN-DEXAMETHASONE (M-DEX) IN PATIENTS WITH AL AMYLOIDOSIS AND ADVANCED ORGAN INVOLVEMENT NOT ELIGIBLE FOR HIGH-DOSE MELPHALAN THERAPY (HDM) [C] . U. Hegenbart, T. Bochtler, J.B. Dengler, International Symposium on Amyloidosis . 2008

机译：使用化学疗法的单中心经验与Melphalan-Dexamethasone（M-DEX）的Al淀粉样蛋白病和先进器官参与没有资格获得高剂量Melphalan治疗（HDM）
5. Performance of a Rules-Based, Electronic Health Record-Driven Severe Asthma Case Finding Algorithm for Clinical Trial Recruitment [D] . Beuther, David Alan. 2019

机译：基于规则的临床试验招聘招聘中的基于规则的电子健康记录驱动的严重哮喘案例发现算法
6. The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma [O] . Kenneth R. Chapman, Frank C. Albers, Bradley Chipps, -1

机译：美泊利珠单抗替代奥马珠单抗在无法控制的严重嗜酸性粒细胞性哮喘中的临床获益
7. Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center’s early clinical experience [O] . Elise Weir, James Paton 2019

机译：Mepolizumab在具有严重嗜酸性嗜酸性哮喘的青少年不符合omalizumab的资格：一个中心的早期临床经验

Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience

著录项

引文网络

相似文献

相关主题

期刊订阅